These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 3378609)

  • 21. Inhibition of endotoxin-induced activation of coagulation and fibrinolysis by pentoxifylline or by a monoclonal anti-tissue factor antibody in chimpanzees.
    Levi M; ten Cate H; Bauer KA; van der Poll T; Edgington TS; Büller HR; van Deventer SJ; Hack CE; ten Cate JW; Rosenberg RD
    J Clin Invest; 1994 Jan; 93(1):114-20. PubMed ID: 8282778
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Platelet activity, coagulation, and fibrinolysis during exercise in healthy males: effects of thrombin inhibition by argatroban and enoxaparin.
    Li N; He S; Blombäck M; Hjemdahl P
    Arterioscler Thromb Vasc Biol; 2007 Feb; 27(2):407-13. PubMed ID: 17138937
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cytotoxicity and effects of T2-toxin on plasma proteins involved in coagulation, fibrinolysis and kallikrein-kinin system.
    Johnsen H; Odden E; Johnsen BA; Bøyum A; Amundsen E
    Arch Toxicol; 1988 Jan; 61(3):237-40. PubMed ID: 3281632
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The role of the fibrinolytic enzyme system in the haemostatic defects following snake envenomation.
    Mohamed AH; Damarawy NA
    Toxicon; 1974 Oct; 12(5):467-75. PubMed ID: 4460282
    [No Abstract]   [Full Text] [Related]  

  • 25. Pathophysiology and clinical aspects of fibrinolysis and inhibition of coagulation. Experimental and clinical studies with special reference to women on oral contraceptives and selected groups of thrombosis prone patients.
    Jespersen J
    Dan Med Bull; 1988 Feb; 35(1):1-33. PubMed ID: 3277796
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Activation of the anticoagulation system following intravenous administration of beta-thrombin].
    Strukova SM; Umarova BA; Semenova OA; Liapina LA; Kudriashov BA
    Fiziol Zh SSSR Im I M Sechenova; 1979 May; 65(5):702-6. PubMed ID: 456683
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of cryoglobulin on fibrin clot formation and fibrinolysis.
    Kataoka K; Yamada S; Toki N
    Acta Haematol; 1984; 71(2):90-6. PubMed ID: 6421060
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Epicatechin influences primary hemostasis, coagulation and fibrinolysis.
    Sinegre T; Teissandier D; Milenkovic D; Morand C; Lebreton A
    Food Funct; 2019 Nov; 10(11):7291-7298. PubMed ID: 31621731
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Stabilization of fibrin clots by activated prothrombin complex concentrate and tranexamic acid in FVIII inhibitor plasma.
    Dai L; Bevan D; Rangarajan S; Sørensen B; Mitchell M
    Haemophilia; 2011 Sep; 17(5):e944-8. PubMed ID: 21371192
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fibrinolysis in the rat after short-term aspirin therapy.
    Housholder GT; Moorrees LL
    J Oral Surg; 1980 Jun; 38(6):412-6. PubMed ID: 6929324
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of Russell's viper venom on blood coagulation, platelets and fibrinolysis.
    Rehman A; Nagi AH; Hayee A
    J Pak Med Assoc; 1983 Apr; 33(4):81-6. PubMed ID: 6410089
    [No Abstract]   [Full Text] [Related]  

  • 32. L-Asparaginase and the effect of age on coagulation and fibrinolysis in childhood acute lymphoblastic leukemia.
    Appel IM; Hop WC; van Kessel-Bakvis C; Stigter R; Pieters R
    Thromb Haemost; 2008 Aug; 100(2):330-7. PubMed ID: 18690355
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Activation of blood coagulation, fibrinolytic and kallikrein systems during storage of plasma.
    Blombäck M; Chmielewska J; Netré C; Akerblom O
    Vox Sang; 1984; 47(5):335-42. PubMed ID: 6209855
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inactivation of plasminogen activator inhibitor type 1 by activated factor XII plays a role in the enhancement of fibrinolysis by contact factors in-vitro.
    Tanaka A; Suzuki Y; Sugihara K; Kanayama N; Urano T
    Life Sci; 2009 Jul; 85(5-6):220-5. PubMed ID: 19500599
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Blood clotting, plasma kinins and fibrinolysis.
    Gjonnaess H; Stormorken H
    Thromb Diath Haemorrh; 1970 Oct; 24(1):308-10. PubMed ID: 5483971
    [No Abstract]   [Full Text] [Related]  

  • 36. [Importance of the structure of the clot in thrombolysis].
    Soria C; Soria J; Mirshahi M; Desvignes P; Bonnet P; Caen JP
    Ann Biol Clin (Paris); 1987; 45(2):207-11. PubMed ID: 2441630
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hormonal treatment of arterial insufficiency in the lower extremities.
    Albrechtsen O; Barfod B; Barfod E; Laursen NP; Nordentoft B; Yde H
    Dan Med Bull; 1972 Jul; 19(5):157-9. PubMed ID: 5049043
    [No Abstract]   [Full Text] [Related]  

  • 38. [Thrombolytic and pharmacodynamic properties of Aspergillus ochraceus protease].
    Klöcking HP; Markwardt F
    Farmakol Toksikol; 1975; 38(3):341-9. PubMed ID: 1084284
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of remote ischaemic conditioning on coagulation and fibrinolysis.
    Kristiansen J; Grove EL; Rise N; Neergaard-Petersen S; Würtz M; Kristensen SD; Hvas AM
    Thromb Res; 2016 May; 141():129-35. PubMed ID: 27018926
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Effect of proteolysis inhibitors from Ascaris lumbricoides on the coagulation and fibrinolysis of human plasma].
    Kadłubowski R; Ochecka A
    Angew Parasitol; 1982 May; 23(2):78-82. PubMed ID: 7125286
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.